Long-Term Cardiovascular Outcomes of Immune Checkpoint Inhibitor-Related Myocarditis: A Large Single-Centre Analysis
This is the largest case-control study on irM highlighting worse long-term CV outcomes. Future studies are needed to establish appropriate therapeutic strategies and efficient screening strategies for irM survivors.
Authors
- Rohit Moudgil (ORCID: https://orcid.org/0000-0001-8258-0675)
- Cassandra Calabrese (ORCID: https://orcid.org/0000-0002-8773-7739)
- Lorenzo Braghieri (ORCID: https://orcid.org/0000-0002-5225-8252)
- Ahmad Gharaibeh
- Amir Mehdizadeh‐Shrifi (ORCID: https://orcid.org/0000-0001-9980-0160)
- Lubika J. Nkashama (ORCID: https://orcid.org/0000-0002-4898-8594)
- Abdelrahman Ibrahim Abushouk (ORCID: https://orcid.org/0000-0003-1399-6487)
- Bianca Honnekeri
- Pauline Funchain (ORCID: https://orcid.org/0000-0002-7568-8626)
- Osama Abu-Shawer
- Venu Menon (ORCID: https://orcid.org/0000-0003-4410-2677)
- Patrick Collier (ORCID: https://orcid.org/0000-0003-3941-9653)
- Diego Sadler (ORCID: https://orcid.org/0000-0001-6268-4127)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Barnes-Jewish Hospital (US)
- Cleveland Clinic (US)
- Cleveland Foundation (US)
- Yale University (US)
- Cleveland Clinic Florida (US)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1002/ehf2.15131
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70